sv8
 

As filed with the Securities and Exchange Commission on August 9, 2002.

Registration No. 333-



SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549


FORM S-8

REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933


SELECT MEDICAL CORPORATION

(Exact name of Registrant as specified in its charter)
         
Delaware


(State of Incorporation)
  4716 Old Gettysburg Road
P. O. Box 2034
Mechanicsburg, Pennsylvania 17055

(Address of principal executive offices)(Zip Code)
  23-2872718


(I.R.S. Employer
Identification No.)

SELECT MEDICAL CORPORATION
SECOND AMENDED AND RESTATED
1997 STOCK OPTION PLAN

(Full Title of the Plans)

Michael E. Tarvin, Esq.
General Counsel
Select Medical Corporation
4716 Old Gettysburg Road
P. O. Box 2034
Mechanicsburg, Pennsylvania 17055
(Name and address of agent for service)
(717) 972-1100
(Telephone number, including area code, of agent for service)

With a Copy to:

Carmen J. Romano, Esq.
Dechert
4000 Bell Atlantic Tower
1717 Arch Street
Philadelphia, Pennsylvania 19103
(215) 994-4000

CALCULATION OF REGISTRATION FEE

                                 
Title Of           Proposed   Proposed        
Securities   Amount   Maximum   Maximum   Amount Of
To Be   To Be   Offering   Aggregate   Registration
Registered   Registered   Price Per Share(1)   Offering Price(1)   Fee

Common Stock of
Select Medical Corporation, par value $.01 per share to be issued under the Plan
  5,419,102 shares   $ 14.32 (1)   $ 77,601,541 (1)   $ 7,139.34  

Common Stock of Select Medical Corporation, par value $.01 per share, to be issued under the Plan
  602,238 shares   $ 14.595 (2)   $ 8,789,664 (2)   $ 808.65  

TOTAL
  6,021,340 shares           $ 86,391,205     $ 7,947.99  


(1)   The registration fee for the shares of Common Stock to be issued pursuant to outstanding options already granted under the Select Medical Corporation Second Amended and Restated 1997 Stock Option Plan (the “Plan”) was calculated in accordance with Rule 457(h) of the Securities Act, based upon the weighted average price per share at which the options may be exercised.
(2)   The registration fee for the shares of Common Stock to be issued pursuant to options reserved but not yet granted under the Plan was calculated in accordance with Rule 457 (c) of the Securities Act, based upon the average of the high and low trading prices of our Common Stock on August 8, 2002.


 

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

         This Registration Statement is filed with the Securities and Exchange Commission (the “Commission”) for the purpose of registering additional shares of Common Stock of the Registrant in connection with the Select Medical Corporation Second Amended and Restated 1997 Stock Option Plan (the “Plan”). A registration statement on Form S-8, file number 333-58424 (the “Prior Registration Statement”) was filed on April 6, 2001 for Common Stock of the Registrant to be offered under the Plan and is currently effective. The contents of the Prior Registration Statement, to the extent not amended by this Registration Statement, are hereby incorporated by reference.

Item 8. Exhibits.

         The following exhibits are filed herewith or incorporated by reference as part of this Registration Statement:

     
Exhibit Number   Description
 
4.1   The relevant portions of the Registrant’s Restated Certificate of Incorporation defining the rights of holders of Common Stock, incorporated herein by reference to Exhibit 3.1 to the registration statement on Form S-1 (File No. 333-48856), as amended.
4.2   Amended and Restated Bylaws of the Registrant, incorporated herein by reference to Exhibit 3.2 to the Registrant’s Form 10-K (File No. 000-32499) filed March 5, 2002.
4.3   Amendment No. 1 to the Amended and Restated Bylaws of the Registrant, incorporated by reference to Exhibit 3.3 to the Registrant’s Form 10-K (File No. 000-32499) filed March 5, 2002.
4.4   Amendment No. 2 to the Amended and Restated Bylaws of the Registrant, incorporated by reference to Exhibit 3.4 to the Registrant’s Form 10-K (File No. 000-32499) filed March 5, 2002.
5.1   Opinion of Dechert (counsel to the Registrant).
23.1   Consent of PricewaterhouseCoopers LLP.
24.1   Power of Attorney (included on signature page).


 

SIGNATURES

         The Registrant. Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Mechanicsburg, Commonwealth of Pennsylvania, on this 9th day of August, 2002.

         
    SELECT MEDICAL CORPORATION
         
    By:   /s/ Robert A. Ortenzio
       
        Robert A. Ortenzio
Chief Executive Officer and President

POWER OF ATTORNEY

         KNOW TO ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Rocco A. Ortenzio, Robert A. Ortenzio and Michael E. Tarvin, each and individually, his attorneys-in-fact, with full power of substitution and resubstitution, for him in any and all capacities, to sign any or all amendments or post-effective amendments to this Registration Statement and to file the same with the Securities and Exchange Commission, granting unto each of such attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary in connection with such matters and hereby ratifying and confirming all that each such attorney-in-fact, or his agent or substitutes, may do or cause to be done by virtue hereof.

         Pursuant to the requirements of the Securities Act of 1933, this Registration Statement and the foregoing Power of Attorney have been signed by the following persons in the capacities and on the date indicated.

         
/s/ Robert A. Ortenzio

Robert A. Ortenzio
  Director, Chief Executive Officer
and President (principal executive
officer)
  August 9, 2002

Date
 
/s/ Rocco A. Ortenzio

Rocco A. Ortenzio
  Executive Chairman
and Director
  August 9, 2002

Date

- 2 -


 

         
 
/s/ Martin F. Jackson

Martin F. Jackson
  Chief Financial Officer
(principal financial officer)
  August 9, 2002

Date
 
/s/ Scott A. Romberger

Scott A. Romberger
  Chief Accounting
Officer(principal)
accounting officer)
  August 9, 2002

Date
 
/s/ Russell L. Carson

Russell L. Carson
  Director   August 9, 2002

Date
 
/s/ Bryan C. Cressey

Bryan C. Cressey
  Director   August 2, 2002

Date
 
 

David S. Chernow
  Director    

Date
 
/s/ James E. Dalton, Jr.

James E. Dalton, Jr.
  Director   August 1, 2002

Date
 
 

Meyer Feldberg
  Director    

Date
 
/s/  Leopold Swergold

Leopold Swergold
  Director   August 5, 2002

Date
 
/s/ LeRoy S. Zimmerman

LeRoy S. Zimmerman
  Director   August 9, 2002

Date

- 3 -


 

EXHIBIT INDEX

     
Exhibit No.   Document
 
4.1   The relevant portions the Registrant’s Restated Certificate of Incorporation defining the rights of holders of Common Stock, incorporated herein by reference to Exhibit 3.1 to the registration statement on Form S-1 (File No. 333-48856), as amended.
4.2   Amended and Restated Bylaws of the Registrant, incorporated herein by reference to Exhibit 3.2 to the Registrant’s Form 10-K (File No. 000-32499) filed March 5, 2002.
4.3   Amendment No. 1 to the Amended and Restated Bylaws of the Registrant, incorporated by reference to Exhibit 3.3 to the Registrant’s Form 10-K (File No. 000-32499) filed March 5, 2002.
4.4   Amendment No. 2 to the Amended and Restated Bylaws of the Registrant, incorporated by reference to Exhibit 3.4 to the Registrant’s Form 10-K (File No. 000-32499) filed March 5, 2002.
5.1   Opinion of Dechert (counsel to the Registrant)
23.1   Consent of PricewaterhouseCoopers LLP
24.1   Power of Attorney (included on signature page)